Press Release: atai Life Sciences launches TryptageniX to further expand atai’s intellectual property portfolio and strengthen atai’s supply chain
Cannabis Law Report
DECEMBER 9, 2021
The launch of TryptageniX demonstrates our ongoing commitment to harness the most promising scientific advancements of our age for the good of patients.”. “TryptageniX’s approach to drug discovery is highly complementary to that of EntheogeniX, our existing AI-enabled drug discovery company. References: Rehm J, Shield KD. Curr Psychiatry Rep.
Let's personalize your content